Ruoxi Chen

Ruoxi Chen is a seasoned professional in the healthcare sector, currently serving as a Managing Director at Warburg Pincus since August 2011. In addition to this role, Ruoxi holds multiple board memberships, including positions at Norstella, Simtra BioPharma Solutions, SOTERA HEALTH LLC, the Chinese-American Planning Council, and Vertice Pharma. Previous experience includes board membership at Polyplus-transfection® and Silk Road Medical, Inc., as well as earlier roles as an Associate at The Carlyle Group and an Investment Banking Analyst at Citigroup Global Markets. Educational qualifications include an MBA from Harvard Business School, a BS in Economics and Computer Science from Duke University, and studies at the University of Oxford.